Abstract
Tobacco smoking is an addictive disorder associated with excessive cardiovascular mortality (1–3). Cigarette smokers have twice the risk of death from coronary artery disease compared with their non-smoking contemporaries. Why cigarettes are addictive is not known with certainty. However, the most likely agent is nicotine (5). Bolus injections of the drug like single puffs of cigarettes result in a rapid rise in the blood concentration, a change in the sensorium and physiologic responses such as increased heart rate, a rise in the blood pressure and peripheral vasconstriction (6,7). Other compounds in this complex aerosol-carbon monoxide, tars, particulate matter, and cyanide-have potentially significantly deleterious effects on the heart and blood vessels as well as the organism as a whole.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Knapp PA, Bliss CM, Wells H. Addictive aspects of heavy cigarette smoking. Am J Psychiatry, 119:966–972 (1973).
Larson PS, Silvette H. Tobacco-Experimental and clinical studies. A comprehensive account of the world literature. Supplement III. Baltimore, MD, The Williams and Wilkins Company (1975).
Klein LW. Cigarette smoking, atherosclerosis and the coronary hemodynamic response: a unifying hypothesis. J Am Coll Cardiol, 4:972–074 (1984).
Kannel WB, Schatzkin A. Risk factor analysis. Prog Cardiovasc Dis, 26:309–332 (1983).
Lader M. Nicotine and smoking behavior. Br J Clin Pharmacol, 5:289–292 (1978).
Armitage AK, Dollery Ct, George CF, Houseman TH, Lewis PG, Turner DM. Absorption and metabolism of nicotine from cigarettes. Br Med J, 4:313 (1975).
Rosenberg J, Benowitz NL, Jacob P, Wilson KM. Disposition kinetics and effects of intravenous nicotine. Clin Pharmacol Ther, 28:517–522 (1980).
Bunting S, Grygleski R, Moncada S, Vane JR. Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin C) which relaxes strips of mesenteric and coeliac arteries and inhibits platelet aggregation. Prostaglandins, 12:897–913 (1976).
Moncada S. Biological importance of prostacyclin. Br J Pharmacol, 76:13–31 (1982).
Moncada S. Prostacyclin and arterial wall biology. Arteriosclerosis 2:193–207 (1982).
Sonnenfeld T, Wennmalm A. Inhibition by nicotine of the formation of prostacyclin-like activity in rabbit and human vascular tissue. Br J Pharmacol, 7:609–613 (1980).
Sanford TD, Colby ED. Effect of zylazine and ketamine on blood pressure, heart rate and respiratory rate in rabbits. Laboratory Science, 30:519–523 (1980).
Tietz NW, Fiereck EA. The spectrophotometric measurement of carboxyhemoglobin. Ann Clin Lab Sci, 3:36–42 (1973).
Born GVR. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature, 194:927–929 (1962).
Ellis EF, Wright KF, Jones PS, Richardson DW, Ellis CK. Effect of oral aspirin dose on platelet aggregation and vascular prostacyclin (PGI2) synthesis in humans and rabbits. J Cardiovasc Pharmacol, 2:387–397 (1980).
Jacob P, Wilson M, Benowitz NL. Improved gas chromatographic method for the determination of nicotine and cotinine in biological fluids. Am J Chromatogr, 222:61–70 (1981).
Marcus AJ, Weksler BB, Jaffe EA, Broekman MJ. Synthesis of prostacyclin from platelet derived endoperoxides by cultured human endothelial cells. J Clin Invest, 66:979–986 (1980).
Spector AA, Kaduce TZ, Hoak JC, Fry GL. Utilization of arachidonic and linoleic acids by cultured human endothelial cells. J Clin Invest, 68:1103–1011 (1981).
Fleischer LN, Tall AR, Witte LD, Miller RW, Cannon PJ. Stimulation of arterial endothelial cell prostacyclin synthesis by high density lipoproteins. J Biol Chem, 57:6653–6655 (1982).
Nowak J Kaijser L, Wennmalm A. Cardiac Synthesis of prostaglandins from arachidonic acid in man. Prostaglandins Med, 4:205–214 (1980).
Wennmalm A. Nicotine inhibits hypoxia and arachidate induced release of prostacyclin like activity in rabbit hearts. Br J Pharmacol, 69:545–549 (1980).
Blair IA, Barrow SE, Wadell KA, Lewis PJ, Dollery CT. L Prostacyclin is not a circulating hormone in man. Prostacyclin, 23:579–589 (1982).
Gerritsen ME, Printz MP. Sites of prostaglandin synthesis in the bovine heart and isolated bovine coronary micro vessels. Circ Res, 49:1152–1163 (1981).
Wennmalm A. Effects of nicotine on cardiac prostaglandin and platelet thromboxane synthesis. Br J Pharmacol, 64:559–563 (1978).
Wennmalm A. Interaction of nicotine and prostaglandins in the cardiovascular system. Prostaglandins, 23:139–144 (1982).
Jaffe JH. Drug addiction and drug abuse. The Pharmacological Basis of Therapeutics, Gilman AG, Goodman LS and Gilman A Eds. New York, McMillan Publishing Co., 535–584 (1980).
Birnstingle MA, Hawkins LA, McEwan T. Experimental atherosclerosis during chronic exposure to carbon monoxide. Eur Surg Res, 2:92–96 (1970).
Birnstingle MA, Brinson K, Chakrabarti BK. The effects of short term exposure to carbon monoxide on platelet stickiness. Br J. Surg, 58:837–839 (1971).
Bellet S, DeGuzman NT, Kostis JB, Roman L, Fleischmann D. The effect of inhalation of cigarette smoke on ventricular fibrillation threshold in normal dogs and dogs with acute myocardial infarction. Am Heart J, 83:67–76 (1972).
Goldsmith JR, Aronow WS. Carbon monoxide and coronary heart disease: a review. Environ Res, 0:236–248 (1975).
Ayres SM, Gianelli S, Mueller H. Effects of low concentrations of carbon monoxide Part IV: Myocardial and systemic responses to carboxyhaemoglobin. An NY Acad Sci, 174:268–293 (1970).
Topping DL. Acute effects of carbon monoxide on the metabolism of perfused rat liver. Biochem J, 152:425–427 (1975).
Wals M, Howard S, Smith PG, Kjeldsen K. Association between atherosclerotic disease and carboxyhaemoglobin levels in tobacco smokers. Br Med J, 1:761–765 (1973).
Hawkins LM, Cole PV, Harris JRW. Smoking habits and blood carbon monoxide levels. Environ Res, 11:310 (1976).
Roughton FJW, Darling RC. The effect of carbon monoxide on the oxyhaemoglobin dissociation curve. Am J Physiol, 141:295–307 (1944).
Qvardfordt PG, Reilly LM, Lusby RJ, Effeney DJ, Ferrell LD, Price DC, Fuller J, Ehrenfeld SK. Prostacyclin production in regions of arterial stenosis. Surgery, 98:484–491 (1985).
Sotel I, Van Der Giessen WJ, Zwolsman E, Quadt FJ, ten Hoor F, Verheugt FW, Hugenholtz PG. Direct effect of nicotine on prostacyclin production in human umbilical arteries. Acta therapeutica, 6:32–38 (1980).
Siggaard-Anderson J, Kjedlsen K, Bond E, Peterson F, Astrup P. A possible connection between carbon monoxide exposure, capillary filtration rate and atherosclerosis. Acta Med Scand, 182:397–399 (1967).
Parving HH. The effect of hypoxia and carbon monoxide on plasma volume and capillary permeability to albumin. Scand J Clin Lab Invest, 30:49–55 (1972).
Langer GA, Brady AJ. The effect of temperature upon contraction and ionic exchange in rabbit ventricular myocardium. J Gen Physiol, 52:682–713 (1968).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Plenum Press, New York
About this chapter
Cite this chapter
Effeney, D.J. (1990). Effect of Nicotine and Carbon Monoxide on Prostacyclin Production by the Rabbit Heart. In: Diana, J.N. (eds) Tobacco Smoking and Atherosclerosis. Advances in Experimental Medicine and Biology, vol 273. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5829-9_22
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5829-9_22
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5831-2
Online ISBN: 978-1-4684-5829-9
eBook Packages: Springer Book Archive